文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于 KIR 的抑制性 CAR 可克服 CAR-NK 细胞 trogocytosis 介导的自相残杀和肿瘤逃逸。

KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.

机构信息

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

UTHealth Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Nat Med. 2022 Oct;28(10):2133-2144. doi: 10.1038/s41591-022-02003-x. Epub 2022 Sep 29.


DOI:10.1038/s41591-022-02003-x
PMID:36175679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9942695/
Abstract

Trogocytosis is an active process that transfers surface material from targeted to effector cells. Using multiple in vivo tumor models and clinical data, we report that chimeric antigen receptor (CAR) activation in natural killer (NK) cells promoted transfer of the CAR cognate antigen from tumor to NK cells, resulting in (1) lower tumor antigen density, thus impairing the ability of CAR-NK cells to engage with their target, and (2) induced self-recognition and continuous CAR-mediated engagement, resulting in fratricide of trogocytic antigen-expressing NK cells (NK) and NK cell hyporesponsiveness. This phenomenon could be offset by a dual-CAR system incorporating both an activating CAR against the cognate tumor antigen and an NK self-recognizing inhibitory CAR that transferred a 'don't kill me' signal to NK cells upon engagement with their TROG siblings. This system prevented trogocytic antigen-mediated fratricide, while sparing activating CAR signaling against the tumor antigen, and resulted in enhanced CAR-NK cell activity.

摘要

细胞融合是一种将靶细胞表面物质转移到效应细胞的主动过程。本研究使用多种体内肿瘤模型和临床数据表明,嵌合抗原受体(CAR)在自然杀伤(NK)细胞中的激活促进了 CAR 同源抗原从肿瘤向 NK 细胞的转移,导致(1)肿瘤抗原密度降低,从而削弱了 CAR-NK 细胞与靶细胞结合的能力,(2)诱导自身识别和连续的 CAR 介导的结合,导致表达 CAR 的 NK 细胞(NK)的细胞融合和 NK 细胞低反应性。通过双重 CAR 系统可以克服这种现象,该系统同时包含针对同源肿瘤抗原的激活 CAR 和 NK 自身识别抑制性 CAR,当与 NK 细胞的“TROG”兄弟结合时,抑制性 CAR 向 NK 细胞传递“不要杀死我”的信号。该系统防止了 trogocytic 抗原介导的细胞融合,同时保留了针对肿瘤抗原的激活 CAR 信号,从而增强了 CAR-NK 细胞的活性。

相似文献

[1]
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.

Nat Med. 2022-10

[2]
Outsmarting trogocytosis to boost CAR NK/T cell therapy.

Mol Cancer. 2023-11-16

[3]
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide.

Cytotherapy. 2023-7

[4]
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.

J Immunother Cancer. 2021-10

[5]
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.

J Transl Med. 2024-3-13

[6]
Targeting KIR as a novel approach to improve CAR-NK cell function.

J Transl Genet Genom. 2023-12-5

[7]
CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

J Immunother Cancer. 2024-2-27

[8]
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.

J Immunother Cancer. 2021-12

[9]
Preclinical Assessment of Suitable Natural Killer Cell Sources for Chimeric Antigen Receptor Natural Killer-Based "Off-the-Shelf" Acute Myeloid Leukemia Immunotherapies.

Hum Gene Ther. 2019-3-18

[10]
NK Cells Equipped With a Chimeric Antigen Receptor That Overcomes Inhibition by HLA Class I for Adoptive Transfer of CAR-NK Cells.

Front Immunol. 2022

引用本文的文献

[1]
The Struggle Between Chimeric Antigen Receptor T-Cell Therapy and Neurological Complications in Acute Lymphoblastic Leukemia Treatment.

Curr Issues Mol Biol. 2025-5-21

[2]
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.

Nat Cancer. 2025-7-22

[3]
Masters of adaptation: How cancer and immune cell plasticity mediates tumor progression.

PLoS Biol. 2025-7-15

[4]
Rendering NK Cells Antigen-Specific for the Therapy of Solid Tumours.

Int J Mol Sci. 2025-6-29

[5]
Cell therapy in pediatric blood diseases.

Front Med (Lausanne). 2025-6-25

[6]
Emerging roles of KIR2DL4 in cancer immunotherapy.

Breast Cancer. 2025-6-23

[7]
Commentary: is trogocytosis relevant for chimeric antigen receptor-T cells?

Oncologist. 2025-6-4

[8]
Peptide based vesicles for cancer immunotherapy: design, construction and applications.

Front Immunol. 2025-5-27

[9]
CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells.

Nature. 2025-6-4

[10]
Emerging Role of Chimeric Antigen Receptor-Natural Killer Cells for the Treatment of Hematologic Malignancies.

Cancers (Basel). 2025-4-26

本文引用的文献

[1]
Balanced engagement of activating and inhibitory receptors mitigates human NK cell exhaustion.

JCI Insight. 2022-8-8

[2]
An NK-like CAR T cell transition in CAR T cell dysfunction.

Cell. 2021-12-9

[3]
Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.

Sci Signal. 2021-11-9

[4]
The Role of Trogocytosis in the Modulation of Immune Cell Functions.

Cells. 2021-5-19

[5]
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells.

Front Immunol. 2021

[6]
Counteracting CAR T cell dysfunction.

Oncogene. 2021-1

[7]
Exploring the NK cell platform for cancer immunotherapy.

Nat Rev Clin Oncol. 2021-2

[8]
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.

Blood. 2021-2-4

[9]
Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma.

Nat Commun. 2020-5-8

[10]
Biting Off What Can Be Chewed: Trogocytosis in Health, Infection, and Disease.

Infect Immun. 2020-6-22

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索